Evidence map›Paper›PMID 42732373›Full record

ArticleHuman mutation2026

Clinical and Genetic Spectrum of Large AIP Deletions.

Tea Shehu Kolnikaj, Maren Ruka, Artur Xhumari, Anila Babameto-Laku, Athanasios Siolos, Panagiotis Alexandros Drakos, Kesson Magid, Thomas O Millner, Robert D Murray, Marinella Tzanela and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tea Shehu KolnikajEndocrinology, American Hospital, University of Medicine, Tirana, Albania, amerikanhastanesi.org.ORCID https://orcid.org/0009-0005-3303-6530
Maren RukaNeurosurgery, Faculty of Medicine, University of Medicine, Tirana, Albania, unito.it.ORCID https://orcid.org/0000-0002-8581-7313
Artur XhumariNeurosurgery, Faculty of Medicine, University of Medicine, Tirana, Albania, unito.it.ORCID https://orcid.org/0000-0002-5941-705X
Anila Babameto-LakuGenetics, Faculty of Medicine, University of Medicine Tirana, Tirana, Albania.ORCID https://orcid.org/0000-0002-8507-5508
Athanasios SiolosDepartment of Endocrinology, Ioannina University Hospital, Ioannina, Greece, uoi.gr.
Panagiotis Alexandros DrakosEndocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK, qmul.ac.uk.ORCID https://orcid.org/0009-0003-1651-0590
Kesson MagidEndocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK, qmul.ac.uk.ORCID https://orcid.org/0000-0003-1155-276X
Thomas O MillnerNeuropathology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK, qmul.ac.uk.ORCID https://orcid.org/0000-0001-5638-3918
Robert D MurrayEndocrinology, University of Leeds, Leeds, UK, leeds.ac.uk.ORCID https://orcid.org/0000-0001-6730-6109
Marinella TzanelaEndocrinology, Evangelismos Hospital, Athens, Greece, evaggelismos-hosp.gr.
Dragana MiljićClinic for Endocrinology, Diabetes and Metabolic Disorders, University Clinical Centre of Serbia, Medical Faculty, Belgrade University, Belgrade, Serbia, bg.ac.rs.ORCID https://orcid.org/0000-0002-3994-4012
Arlinda RamajLocal Health Care Unit, Department of Epidemiology and Environmental Health, Tirana, Albania.ORCID https://orcid.org/0000-0001-7701-1902
Paul Benjamin LoughreyDepartment of Endocrinology, Beaumont Hospital, Dublin, Ireland, beaumont.edu.ORCID https://orcid.org/0000-0002-5491-6730
Stelios TigasDepartment of Endocrinology, Ioannina University Hospital, Ioannina, Greece, uoi.gr.ORCID https://orcid.org/0000-0001-7325-8983
Márta KorbonitsEndocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK, qmul.ac.uk.ORCID https://orcid.org/0000-0002-4101-9432

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial isolated pituitary adenoma (FIPA) accounts for approximately 2%-5% of all pituitary adenomas, with inactivating variants of the aryl hydrocarbon receptor-interacting protein (

Indexed as

Intracellular Signaling Peptides and ProteinsSequence DeletionAdultDNA Copy Number VariationsExonsFemaleGenetic Association StudiesGrowth Hormone-Secreting Pituitary AdenomaHumansMaleMiddle AgedPedigreePhenotypePituitary Neoplasmsaryl hydrocarbon receptor-interacting proteinIntracellular Signaling Peptides and ProteinsacromegalyAIP genefamilial isolated pituitary adenomagenetic mutationHürthle cell thyroid carcinoma

Identifiers

PMID42732373
PMCPMC13570415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.